当前位置:首页 - 行情中心 - 方盛制药(603998) - 财务分析

方盛制药

(603998)

  

流通市值:51.20亿  总市值:51.20亿
流通股本:4.39亿   总股本:4.39亿

方盛制药(603998)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润2.65亿元,每股收益0.61元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益175218.72万元,未分配利润92566.98万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产303150.28万元,负债127931.56万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,253,315,302.11834,248,975.63418,083,503.371,777,494,393.87
营业总成本1,022,150,726.68683,068,914.91340,146,773.391,531,784,897.55
其他经营收益
营业利润299,828,760.83187,112,626.8499,305,191.5285,344,284.91
利润总额299,162,496.92186,493,310.7199,168,320.14285,987,541.69
净利润265,351,950.55166,494,080.2288,724,501.72249,848,866.44
每股收益
其他综合收益-65,219.22---
综合收益总额265,286,731.33166,494,080.2288,724,501.72249,848,866.44
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计987,649,695.53940,136,070.641,007,066,535.21,137,539,132.24
非流动资产:
非流动资产合计2,043,853,141.372,116,407,088.062,142,934,073.892,129,034,332.35
资产总计3,031,502,836.93,056,543,158.73,150,000,609.093,266,573,464.59
流动负债:
流动负债合计1,149,548,620.361,167,605,565.81,214,371,255.411,298,529,448.16
非流动负债:
非流动负债合计129,766,967.57174,190,717.88176,143,794.69233,175,717.78
负债合计1,279,315,587.931,341,796,283.681,390,515,050.11,531,705,165.94
所有者权益(或股东权益):
归属于母公司股东权益合计1,672,016,819.11,638,839,547.981,666,208,152.731,622,965,416.79
股东权益合计1,752,187,248.971,714,746,875.021,759,485,558.991,734,868,298.65
负债和股东权益合计3,031,502,836.93,056,543,158.73,150,000,609.093,266,573,464.59
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,302,807,585.71837,217,170.97394,398,253.081,822,980,615.31
经营活动现金流出小计1,077,931,339.97707,728,803.3372,472,153.731,628,033,176.75
经营活动产生的现金流量净额224,876,245.74129,488,367.6721,926,099.35194,947,438.56
投资活动产生的现金流量:
投资活动现金流入小计640,139,688.45320,696,460.3379,147,130.64213,501,716.3
投资活动现金流出小计588,509,679.01307,298,903.2877,932,275.96172,458,127.7
投资活动产生的现金流量净额51,630,009.4413,397,557.051,214,854.6841,043,588.6
筹资活动产生的现金流量:
筹资活动现金流入小计342,480,000334,025,000157,325,000910,594,583.33
筹资活动现金流出小计745,608,590.67658,260,770.36303,674,023.621,032,594,628.44
筹资活动产生的现金流量净额-403,128,590.67-324,235,770.36-146,349,023.62-122,000,045.11
汇率变动对现金及现金等价物的影响-16,775.9-0.19-0.060.67
现金及现金等价物净增加额-126,639,111.39-181,349,845.83-123,208,069.65113,990,982.72
期末现金及现金等价物余额169,389,737.12114,672,186.92172,813,963.89296,022,032.75
补充资料:
现金及现金等价物的净增加额--181,349,845.83-113,990,982.72
最新报告期:2025-11-27
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券宋硕,陈竹,李文涛0.690.770.922025-11-27
信达证券唐爱金,章钟涛0.720.861.092025-10-31
中泰证券孙宇瑶,祝嘉琦0.720.881.062025-10-28
华泰证券代雯,唐庆雷,张云逸0.700.831.002025-10-27
东吴证券朱国广0.700.861.032025-10-27
TOP↑